🕵️ Agios Pharmaceuticals, Inc. ($AGIO)
SEC insider & ownership activity, last 12 months · CIK 1439222 · every row links its SEC filing
Over the last 12 months insiders sold $4.7M with no open-market buying against it. Goff Brian sold $2.1M through a 10b5-1 trading plan in 8 lots (Aug–Apr). No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 8 sellers, $4.7M (46 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Goff Brian | 0 | – | 8 | $2.1M | Apr 2, 2026 |
| Gheuens Sarah | 0 | – | 9 | $711K | Jul 1, 2026 |
| Washburn Theodore James Jr. | 0 | – | 5 | $532K | Mar 3, 2026 |
| Jones Cecilia | 0 | – | 7 | $469K | Apr 2, 2026 |
| Milanova Tsveta | 0 | – | 5 | $353K | Apr 2, 2026 |
| Burns James William | 0 | – | 6 | $344K | Apr 2, 2026 |
| Viswanadhan Krishnan | 0 | – | 2 | $185K | Apr 2, 2026 |
| Scadden David | 0 | – | 4 | $33K | Nov 12, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Joshua J. Dapice | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| Dreyfuss, Philip D. | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| Hannah E. Dunn | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| Gehani, Varun N. | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| Giauque, Nicolas | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| Husen, Avner A. | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| KIM, David T. | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| LINN, Michael G. | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| LUO Patrick (CHENG) | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| Roberts, JR., Thomas G. | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| Edric C. Saito | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| Daniel S. Short | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| Spokes, Andrew J. M. | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| Warren, JOHN R. | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| Wehrly, MARK C. | 8.8% | 13G | Feb 9, 2026 | filing ↗ | |
| Farallon Partners, L.L.C. | 8.7% | 13G | Feb 9, 2026 | filing ↗ | |
| Blackrock, Inc. | 7.8% | 13G | Jul 17, 2025 | filing ↗ | |
| State Street Corporation | 5.3% | 13G | Feb 9, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.3% | 13G | Apr 29, 2026 | filing ↗ | |
| D. E. SHAW & Co., L.P. | 5.1% | 13G | Jul 2, 2026 | filing ↗ | |
| David E. Shaw | 5.1% | 13G | Jul 2, 2026 | filing ↗ | |
| LYNX1 Capital Management LP | 5.1% | 13G | May 6, 2026 | filing ↗ | |
| Weston Nichols | 5.1% | 13G | May 6, 2026 | filing ↗ | |
| Farallon Healthcare Partners Master, L.P. | 5.0% | 13G | Feb 9, 2026 | filing ↗ | |
| Farallon Healthcare Partners (GP), L.L.C. | 5.0% | 13G | Feb 9, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Gheuens Sarah | $151K | Jul 1, 2026 | filing ↗ |
| Goff Brian | $652K | Apr 2, 2026 | filing ↗ |
| Jones Cecilia | $107K | Apr 2, 2026 | filing ↗ |
| Viswanadhan Krishnan | $101K | Apr 2, 2026 | filing ↗ |
| Milanova Tsveta | $112K | Apr 2, 2026 | filing ↗ |
| Gheuens Sarah | $101K | Apr 2, 2026 | filing ↗ |
| Burns James William | $112K | Apr 2, 2026 | filing ↗ |
| Viswanadhan Krishnan | $86K | Mar 5, 2026 | filing ↗ |
| Goff Brian | $546K | Mar 2, 2026 | filing ↗ |
| Burns James William | $158K | Mar 2, 2026 | filing ↗ |
| Gheuens Sarah | $123K | Mar 2, 2026 | filing ↗ |
| Jones Cecilia | $152K | Mar 2, 2026 | filing ↗ |
| Milanova Tsveta | $87K | Mar 2, 2026 | filing ↗ |
| Milanova Tsveta | $78K | Jan 5, 2026 | filing ↗ |
| Goff Brian | $508K | Dec 30, 2025 | filing ↗ |
| Gheuens Sarah | $80K | Dec 30, 2025 | filing ↗ |
| Jones Cecilia | $80K | Dec 30, 2025 | filing ↗ |
| Milanova Tsveta | $80K | Dec 30, 2025 | filing ↗ |
| Burns James William | $80K | Dec 30, 2025 | filing ↗ |
| Sarah Gheuens | $107K | Nov 11, 2025 | filing ↗ |
| Sarah Gheuens | $9K | Oct 30, 2025 | filing ↗ |
| Sarah Gheuens | $145K | Oct 27, 2025 | filing ↗ |
| David Scadden | $8K | Oct 8, 2025 | filing ↗ |
| David Scadden | $8K | Sep 30, 2025 | filing ↗ |
| Jones Cecilia | $134K | Sep 26, 2025 | filing ↗ |
| David T. Scadden | $8K | Aug 27, 2025 | filing ↗ |
| Goff Brian | $411K | Aug 8, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 18, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Earnings (2.02) | Apr 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Earnings (2.02) | Feb 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Earnings (2.02) | Oct 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 30, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 4, 2025 | filing ↗ |
| Earnings (2.02) | Jul 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2025 | filing ↗ |